Form 4 for WST West Pharmaceutical Services
Accepted 2021-09-14 00:00:00 ET · period of report 2021-09-10 · accession 0001562180-21-005939 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-14 | 2021-09-10 | WST | Lai Quintin J | VP Corp Development, Strategy | M - OptEx | $61.02 | +9,672 | 11.9K | +433% | +$590.2K |
| DM | 2021-09-14 | 2021-09-10 | WST | Lai Quintin J | VP Corp Development, Strategy | S - Sale+OE | $460.76 | -9,672 | 2,234 | -81% | -$4.46M |
| DM | 2021-09-14 | 2021-09-10 | WST | Lai Quintin J | VP Corp Development, Strategy | M - OptEx | $0.00 | -9,672 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-10 | M | A | 8,672 | $59.64 | 10,905.84 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-10 | M | A | 1,000 | $72.97 | 11,905.84 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-10 | S | D | 3,100 | $460.80 | 3,733.84 | D | — | — | (F2) The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $460.50 to $461.44, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. |
| 4 | Common | Common Stock | 2021-09-10 | S | D | 5,072 | $460.18 | 6,833.84 | D | — | — | (F1) The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $459.50 to $460.44, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. |
| 5 | Common | Common Stock | 2021-09-10 | S | D | 1,500 | $462.63 | 2,233.84 | D | — | — | (F3) The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $462.48 to $462.805, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-09-10 | M | D | 1,000 | $0.00 | 0 | D | $72.97 · 2017-10-18 to 2026-10-18 | 1,000 Common Stock | |
| 7 | Derivative | Stock Option (Right to Buy) | 2021-09-10 | M | D | 8,672 | $0.00 | 0 | D | $59.64 · 2017-02-23 to 2026-02-23 | 8,672 Common Stock |